Effective 7/1/2023

4-41a-1201.  Medical cannabis home delivery designation.

(1)  The department may designate a medical cannabis pharmacy as a home delivery medical cannabis pharmacy if the department determines that the medical cannabis pharmacy‘s operating plan demonstrates the functional and technical ability to:

Terms Used In Utah Code 4-41a-1201

  • Cannabis: means the same as that term is defined in Section 26B-4-201. See Utah Code 4-41a-102
  • Cannabis product: means the same as that term is defined in Section 26B-4-201. See Utah Code 4-41a-102
  • Department: means the Department of Agriculture and Food. See Utah Code 4-41a-102
  • Home delivery medical cannabis pharmacy: means a medical cannabis pharmacy that the department authorizes, as part of the pharmacy's license, to deliver medical cannabis shipments to a delivery address to fulfill electronic orders that the state central patient portal facilitates. See Utah Code 4-41a-102
  • Medical cannabis: means the same as that term is defined in Section 26B-4-201. See Utah Code 4-41a-102
  • Medical cannabis pharmacy: means the same as that term is defined in Section 26B-4-201. See Utah Code 4-41a-102
  • State: when applied to the different parts of the United States, includes a state, district, or territory of the United States. See Utah Code 68-3-12.5
(a)  safely conduct transactions for medical cannabis shipments;

(b)  accept electronic medical cannabis orders that the state central patient portal facilitates; and

(c)  accept payments through:

(i)  a payment provider that the Division of Finance approves, in consultation with the state treasurer, in accordance with Section 26-61a-603; or

(ii)  a financial institution in accordance with Subsection 26-61a-603(4).

(2)  An applicant seeking a designation as a home delivery medical cannabis pharmacy shall identify in the applicant’s operating plan any information relevant to the department’s evaluation described in Subsection (1), including:

(a)  the name and contact information of the payment provider;

(b)  the nature of the relationship between the prospective licensee and the payment provider;

(c)  the processes of the following to safely and reliably conduct transactions for medical cannabis shipments:

(i)  the prospective licensee; and

(ii)  the electronic payment provider or the financial institution described in Subsection (1)(c); and

(d)  the ability of the licensee to comply with the department’s rules regarding the secure transportation and delivery of medical cannabis or medical cannabis product to a medical cannabis cardholder.

(3)  Notwithstanding any county or municipal ordinance, a medical cannabis pharmacy that the department designates as a home delivery medical cannabis pharmacy may deliver medical cannabis shipments in accordance with this part.

Enacted by Chapter 273, 2023 General Session